Dr Phillip Marzella is Chief Operating Officer of the O’Brien Institute, Chief Executive Officer of the O’Brien Foundation, Acting Chief Executive Officer of the Australian Tissue Engineering Centre (ATEC) and Board Director of Neopec Pty Ltd.
With a strong business and biotechnology background, Dr Marzella is an innovative senior manager of commercialisation in the research and development sector. He has a background in biochemistry and genetics, holding a PhD in neuropharmacology from The University of Melbourne. Prior to his current roles, Dr Marzella was Innovation Manager at Dairy Australia, delivering large-scale collaborative research opportunities.
A Member of the Australian Institute of Company Directors, Phillip has extensive experience in governance, compliance, policy development, and business and organisational reform. He is a keen innovator and proponent of latest innovative management thinking.
Dr Phillip Marzella will provide a presentation focused on tissue engineering advances and prospect of organ regeneration.
Chief Operating Officer
Chief Executive Officer
“A successful man is one who can lay a firm foundation with the bricks others have thrown at him.” – David Brinkley.
“Consistency is contrary to nature, contrary to life. The only completely consistent people are dead.” – Aldous Huxley (English Novelist and Critic, 1894-1963)
Phillip Marzella - “Transplants made to order” – Today, Melbourne is at the centre of the world of microsurgery.
The O’Brien Institute has led the way in clinical and experimental research over the past 30 years. The Institute has made striking advances in the delicate craft of replantation surgery and the transfer by microsurgical techniques of body parts and tissue to reconstruct people maimed by trauma, cancer, burns and congenital deformity.
In addition to pioneering techniques in reconstructive microsurgery, the Institute carries out internationally recognised scientific research in the fields of Tissue Engineering and Vascular Biology. We also carry out studies on wound healing, nerve regeneration, inflammation, pain, the effects of trauma on tissue, and more recently, prostate cancer.
The Institute’s scientists have pursued excellence and led the way in
tissue engineering research. The ability of tissue engineering to restore hope and dignity is close to becoming a reality.